Suppr超能文献

通过抑制c-Abl激酶调节桩蛋白酪氨酸磷酸化以保护大鼠体内呼吸机诱导的肺损伤

[Regulation of paxillin tyrosine phosphorylation via inhibition of c-Abl kinase to protect ventilator induce lung injury in vivo in rats].

作者信息

Zhong Rong, Xiao Jun, Dai Chunguang, Yu Zhihui

机构信息

Department of Critical Care Medicine, Affiliated Hospital of Guilin Medical College, Guilin 541001, Guangxi, China. Corresponding author: Xiao Jun, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jul;29(7):596-601. doi: 10.3760/cma.j.issn.2095-4352.2017.07.005.

Abstract

OBJECTIVE

To determine whether the inhibition of paxillin tyrosine residues 31 and tyrosine residues 118 (Pxn Y31 and Pxn Y118) phosphorylation via inhibition of c-Abl kinase will effectively block its downstream effector molecules vessel endothelium-cadherin (VE-cad), and whether Rho/Rho kinase activation which will induce the vascular barrier dysfunction.

METHODS

Ninety healthy male Sprague-Dawley (SD) rats were randomly divided into nine groups (each n =10). Only tracheotomy was undergone in the sham group. Groups of protective ventilation were set at a volume tidal (VT) of 6 mL/kg, a positive end-expiratory pressure (PEEP) of 5 cmHO (1 cmHO = 0.098 kPa) for 1 hour or 2 hours (namely group PVT 1 h and group PVT 2 h), respectively. Groups of high VT were put on mechanical ventilation (MV) at high VT 30 mL/kg, PEEP 0 for 1 hour or 2 hours (namely group HVT 1 h and group HVT 2 h), respectively. Groups UO126 and AG957 pretreatment were set on MV at HVT for 1 hour or 2 hour respectively, but they were given p42/44 mitogen-activated protein kinase (p42/44MAPK) inhibitor UO126 1 mg/kg by intraperitoneal injection or c-Abl kinase inhibitor AG957 10 mL/kg by intragastric injection 1 hour before HVT ventilation. All the animals were sacrificed after experiments and specimens of lung tissues and bronchoalveolar lavage fluid (BALF) were harvested. Pulmonary vascular permeability was measured by Evans blue (EB). The levels of tumor necrosis factor-α (TNF-α) in BALF were measured by enzyme linked immunosorbent assay (ELISA). Then the change of lung tissue pathology was observed with light microscope, diffuse alveolar damage system (DAD) score and lung wet/dry ratio (W/D) were estimated. The myeloperoxidase (MPO) activity was measured by colorimetric analysis, phosphorylations of c-Abl Y245, Pxn Y31, Pxn Y118, VE-cad Y658, p42/44MAPK Y202/Y204, myosin light chain (MLC) and myosin-associated phosphatasetype Y696 (MYPT Y696) were determined by Western Blot.

RESULTS

(1)There were no obvious pathological changes in the lung tissue in the sham group and PVT 1 h or 2 h group, and also there were no significant differences in all the parameters between above groups. However, the injury in lung tissue was severe in the HVT groups. In addition, DAD score, lung W/D ratio, EB content, the activity of MPO, and TNF-α in BALF in HVT groups were significantly higher than those in sham group and PVT groups. After pretreatment with AG957 or UO126, all the parameters were significantly decreased as compared with those of groups HVT. (2) The levels of phosphorylation of the proteins in lung tissue in HVT groups were increased as compared with those of group sham and groups PVT, especially at 2 hours of MV. However, compared with groups HVT, the level of p-VE-cad Y658 in lung tissue decreased significantly in group AG957 and group UO126 at 2 hours after HVT. However, the levels of all phosphorylated proteins at 2 hours were significantly lowered in the AG957 group compared with those of the HVT group [p-c-Abl Y245 (gray value): 0.29±0.04 vs. 0.42±0.04, p-Pxn Y31 (gray value): 0.51±0.03 vs. 0.70±0.05, p-Pxn Y118 (gray value): 0.65±0.04 vs. 0.91±0.04, p-VE-cad Y658 (gray value): 0.77±0.07 vs. 1.32±0.07, p-p42/44MAPK Y202/Y204 (gray value): 0.38±0.06 vs. 0.61±0.03, p-MLC (gray value): 0.37±0.04 vs. 0.77±0.05, p-MYPT Y696 (gray value): 0.54±0.05 vs. 0.87±0.06, all P < 0.05]. After pretreatment with UO126, the phosphorylation level of VE-cad in lung tissue at 2 hours was significantly lower than that of HVT group (gray value: 0.74±0.04 vs. 1.32±0.07), and the phosphorylation levels of p42/44MAPK and its downstream effector molecules MLC and MYPT Y696 were also significantly decreased [p-p42/44MAPK Y202/Y204 (gray value): 0.38±0.07 vs. 0.61±0.03, p-MLC (gray value): 0.37±0.04 vs. 0.77±0.05, p-MYPT Y696 (gray value): 0.55±0.05 vs. 0.87±0.06, all P < 0.05].

CONCLUSIONS

Pxn Y31 and Pxn Y118 phosphorylation could be blocked by inhibition of c-Abl kinase, which could strengthen VE-cad at attachment junction and might block formation of Pxn-guanine nucleotide-exchange factor H1 (GEF-H1)-p44/42MAPK signalosome which induce activation local Rho signaling, lead to activation of MLC phosphorylation, actomyosin contraction, and increase endothelial permeability.

摘要

目的

通过抑制c-Abl激酶来确定抑制桩蛋白酪氨酸残基31和酪氨酸残基118(Pxn Y31和Pxn Y118)磷酸化是否会有效阻断其下游效应分子血管内皮钙黏蛋白(VE-cad),以及Rho/Rho激酶激活是否会诱导血管屏障功能障碍。

方法

将90只健康雄性Sprague-Dawley(SD)大鼠随机分为9组(每组n = 10)。假手术组仅行气管切开术。保护性通气组分别设置潮气量(VT)为6 mL/kg、呼气末正压(PEEP)为5 cmH₂O(1 cmH₂O = 0.098 kPa),通气1小时或2小时(即PVT 1 h组和PVT 2 h组)。高VT组分别以高VT 30 mL/kg、PEEP为0进行机械通气(MV)1小时或2小时(即HVT 1 h组和HVT 2 h组)。UO126和AG957预处理组分别在HVT下进行MV 1小时或2小时,但在HVT通气前1小时腹腔注射p42/44丝裂原活化蛋白激酶(p42/44MAPK)抑制剂UO126 1 mg/kg或灌胃给予c-Abl激酶抑制剂AG957 10 mL/kg。实验结束后处死所有动物,采集肺组织和支气管肺泡灌洗液(BALF)标本。用伊文思蓝(EB)测定肺血管通透性。用酶联免疫吸附测定(ELISA)法测定BALF中肿瘤坏死因子-α(TNF-α)水平。然后用光学显微镜观察肺组织病理变化,评估弥漫性肺泡损伤系统(DAD)评分和肺湿/干比(W/D)。用比色分析法测定髓过氧化物酶(MPO)活性,用蛋白质免疫印迹法测定c-Abl Y245、Pxn Y31、Pxn Y118、VE-cad Y658、p42/44MAPK Y202/Y204、肌球蛋白轻链(MLC)和肌球蛋白相关磷酸酶Y696(MYPT Y696)的磷酸化水平。

结果

(1)假手术组、PVT 1 h组或PVT 2 h组肺组织无明显病理变化,上述各组各项参数也无显著差异。然而,HVT组肺组织损伤严重。此外,HVT组的DAD评分、肺W/D比值、EB含量、MPO活性及BALF中TNF-α水平均显著高于假手术组和PVT组。用AG957或UO126预处理后,与HVT组相比,所有参数均显著降低。(2)与假手术组和PVT组相比,HVT组肺组织中蛋白磷酸化水平升高,尤其是在MV 2小时时。然而,与HVT组相比,HVT后2小时AG957组和UO126组肺组织中p-VE-cad Y658水平显著降低。然而,与HVT组相比,AG957组2小时时所有磷酸化蛋白水平均显著降低[p-c-Abl Y245(灰度值):0.29±0.04对0.42±0.04,p-Pxn Y31(灰度值):0.51±0.03对0.70±0.05,p-Pxn Y118(灰度值):0.65±0.04对0.91±0.04,p-VE-cad Y658(灰度值):0.77±0.07对1.32±0.07,p-p42/44MAPK Y202/Y204(灰度值):0.38±0.06对0.61±0.03,p-MLC(灰度值):0.37±0.04对0.77±0.05,p-MYPT Y696(灰度值):0.54±0.05对0.87±0.06,均P < 0.05]。用UO126预处理后,肺组织中VE-cad在2小时时的磷酸化水平显著低于HVT组(灰度值:0.74±0.04对1.32±0.07),p42/44MAPK及其下游效应分子MLC和MYPT Y696的磷酸化水平也显著降低[p-p42/44MAPK Y202/Y204(灰度值):0.38±0.07对0.61±0.03,p-MLC(灰度值):0.37±I04对0.77±0.05,p-MYPT Y696(灰度值):0.55±0.05对0.87±0.06,均P < 0.05]。

结论

抑制c-Abl激酶可阻断Pxn Y31和Pxn Y118磷酸化,增强附着连接处的VE-cad,并可能阻断由Pxn-鸟嘌呤核苷酸交换因子H1(GEF-H1)-p44/42MAPK信号小体诱导的局部Rho信号激活,导致MLC磷酸化激活、肌动球蛋白收缩,增加内皮通透性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验